MATERIAL SAFETY DATA SHEET
PRODUCT NAME: DURA-FLEX-SF
SECTION I - IDENTIFICATION
HMIS HAZARD RATING
LEAST ---0 Slight---1
MODERATE---2 HIGH---3
EXTREME---4
NAME: Silvertree Products, LLC
ADDRESS: 5120 Investment Dr. Ft. Wayne, IN. 46808 INFORMATION PHONE: 260-482-2474
DATE REVISED: MARCH 2005 EMERGENCY CONTACT (CHEMTREC): 800-424-9300
SECTION I - HAZARDOUS INGREDIENTS/SARA I INFORMATION
OCCUPATIONAL EXPOSURE LIMITS VAPOR PRESSURE
CAS NUMBER OSHA PEL ACGIH TLV MFG TLV mm Hg @ TEMP
HAZARDOUS COMPONENTS
? ?br>
26471-62-5 .005 ppm .005 ppm
*TOLUENE DIISOCYANATE(T.D.I.) 0.025 25 C(77 F)
(STEL-.02 ppm)
N/E
URETHANE PREPOLYMER N/E 0 0
103-23-1 N/E NEGLIGIBLE 20 C (68 F)
1-2 ETHYLHEXYLADIPATE N/E 300 ppm
* Indicates toxic chemical(s) subject to the reporting
requirements of section 313 of Title III and of 40 CFR 372. Information concerning non-hazardous ingredients
is considered a Trade Secret.
SECTIONI - PHYSICAL/CHEMICAL CHARACTERISTICS
BOILING POINT: >163鸆(325鸉) SPECIFIC GRAVITY: (H2O=1): 1.2
COATING V.O.C: <118 G/L (0.98 LB/GAL) VAPOR DENSITY: HEAVIER THAN AIR
EVAPORATION RATE: SLOWER THAN ETHER SOLUBILITY IN WATER: REACTS WITH WATER
APPEARANCE AND ODOR: VISCOUS PIGMENT LIQUID, MILD CHEMICAL ODOR
SECTION IV - FIRE AND EXPLOSION HAZARD DATA
FLASH POINT: >93鸆(200鸉) METHOD USED: TCC
FLAMMABLE LIMITS IN AIR BY VOLUME - LOWER: N/E UPPER: N/E
EXTINGUISHING MEDIA: DRY CHEMICAL, FOAM, CARBON DIOXIDE. IF WATER IS USED, USE VERY LARGE QUANTITIES OF COLD
WATER. THE REACTION BETWEEN WATER AND HOT ISOCYANATE MAY BE VIGOROUS.
SPECIAL FIRE FIGHTING PROCEDURES: WEAR NIOSH APPROVED SELF CONTAINED BREATHING APPARATUS IN POSITIVE PRES-
SURE MODE WITH FULL FACE PIECE. BOOTS, GLOVES (NEOPRENE), GOGGLES, AND FULL PROTECTIVE CLOTHING ARE ALSO REQUIRED.
EXCESSIVE PRESSURE OR TEMPERATURE MAY CAUSE EXPLOSIVE RUPTURE OF CONTAINERS. WATER OR FOAM MAY CAUSE VIOLENT
FROTHING AND POSSIBLY ENDANGER THE LIFE OF THE FIRE FIGHTER.
UNUSUAL FIRE AND EXPLOSION HAZARDS: WATER CONTAMINATION WILL PRODUCE CARBON DIOXIDE. DO NOT RESEAL
CONTAMINATED CONTAINERS AS PRESSURE BUILDUP MAY RUPTURE THEM.
SECTION V - REACTIVITY DATA
STABILITY: STABLE UNDER NORMAL CONDITIONS
CONDITIONS TO AVOID: HEAT, HIGH TEMPERATURE, OPEN FLAME, SPARKS, AND MOISTURE. CONTACT WITH INCOMPATIBLE
MATERIALS IN A CLOSED SYSTEM WILL CAUSE LIBERATION OF CARBON DIOXIDE AND BUILDUP OF PRESSURE.
INCOMPATIBILITY (MATERIALS TO AVOID): THIS PRODUCT WILL REACT WITH ANY MATERIAL CONTAINING ACTIVE HYDROGENS,
?br>
SUCH AS WATER, ALCOHOL, AMMONIA, AMINES, ALKALIS AND ACIDS, THE REACTION WITH WATER IS VERY SLOW UNDER 50 C, BUT IS
ACCELERATED AT HIGHER TEMPERATURE AND IN THE PRESENCE OF ALKALIS, TERTIARY AMINES, AND METAL COMPOUNDS. SOME
REACTIONS CAN BE VIOLENT. MATERIAL CAN REACT WITH STRONG OXIDIZING AGENTS.
HAZARDOUS DECOMPOSITION OR BY-PRODUCTS: CARBON DIOXIDE, CARBON MONOXIDE, NITROGEN OXIDES, TRACE AMOUNTS
OF HYDROGEN CYANIDE AND UNIDENTIFIED ORGANIC COMPOUNDS MAY BE FORMED DURING COMBUSTION.
HAZARDOUS POLYMERIZATION: WILL NOT OCCUR UNDER NORMAL CONDITIONS BUT UNDER HIGH TEMPERATURES IN THE PRES-
ENCE OF ALKALIS, TERTIARYAMINES, AND METAL COMPOUNDS WILLACCELERATE POLYMERIZATION. POSSIBLE EVOLUTION OF CARBON
DIOXIDE GAS MAY RUPTURE CLOSED CONTAINERS.
Page 1 of 4 DURA-FLEX-SF
SECTION VI - HEALTH HAZARD DATA
SKIN CONTACT: ISOCYANATES REACT WITH SKIN PROTEIN AND MOISTURE AND CAN CAUSE IRRITATION. PROLONGED CONTACT CAN
CAUSE REDDENING, SWELLING, RASH, SCALING, BLISTERING, AND IN SOME CASES, SKIN SENSITIZATION. INDIVIDUALS WHO HAVE
DEVELOPED A SKIN SENSITIZATION CAN DEVELOP THESE SYMPTOMS AS A RESULT OF CONTACT WITH VERY SMALL AMOUNTS OF LIQ-
UID MATERIAL OR AS A RESULT OF EXPOSURE TO VAPOR.
EYE CONTACT: LIQUID, AEROSOLS OR VAPORS ARE SEVERELY IRRITATING AND CAN CAUSE PAIN, TEARING, REDDENING AND
SWELLING. PROLONGED CONTACT MAY CAUSE CONJUNCTIVITIS. ANY LEVEL OF CONTACT SHOULD NOT BE LEFT UNTREATED.
SKIN ABSORPTION: SYSTEMICALLY TOXIC CONCENTRATIONS OF THIS PRODUCT WILL PROBABLY NOT BE ABSORBED THROUGH
HUMAN SKIN.
INGESTION: CAN RESULT IN IRRITATING AND CORROSIVE ACTION IN THE MOUTH, STOMACH TISSUE AND DIGESTIVE TRACT.
SYMPTOMS CAN INCLUDE SORE THROAT, ABDOMINAL PAIN, NAUSEA, VOMITING AND DIARRHEA. SMALL AMOUNTS OF THIS PROD-
UCT ASPIRATED INTO THE RESPIRATORY SYSTEM DURING INGESTION OR VOMITING MAY CAUSE MILD TO SEVERE PULMONARY
INJURY.
INHALATION: TDI VAPORS OR MIST AT CONCENTRATIONS ABOVE THE TLV CAN IRRITATE (BURNING SENSATION) THE MUCOUS MEM-
BRANES IN THE RESPIRATORY TRACT (NOSE, THROAT, LUNGS) CAUSING RUNNY NOSE, SORE THROAT, COUGHING, CHEST DISCOM-
FORT, SHORTNESS OF BREATH AND REDUCED LUNG FUNCTION (BREATHING OBSTRUCTION). HIGH VAPOR CONCENTRATIONS MAY
CAUSE HEADACHE, DIZZINESS, ANESTHESIA, DROWSINESS, LOSS OF CONSCIOUSNESS, AND OTHER CENTAL NERVOUS SYSTEM (CSN)
EFFECTS. PERSONS WITH A PRE-EXISTING, NON-SPECIFIC BRONCHIAL HYPERACTIVITY CAN RESPOND TO CONCENTRATIONS BELOW
THE TLV WITH SIMILAR SYMPTOMS AS WELL AS ASTHMA ATTACK. EXPOSURE WELL ABOVE THE TLV MAY LEAD TO BRONCHITIS,
BRONCHIAL SPASM AND PULMONARY EDEMA (FLUID IN LUNGS). AS A RESULT OF PREVIOUS REPEATED OVER EXPOSURE OR A SINGLE
LARGE DOSE, CERTAIN INDIVIDUALS MAY DEVELOP ISOCYANATE SENSITIZATION (CHEMICAL ASTHMA) WHICH WILL CAUSE THEM TO
REACT TO A LATER EXPOSURE TO ISOCYANATE AT LEVELS WELL BELOW THE TLV. SIMILAR TO MANY NON-SPECIFIC ASTHMATIC
RESPONSES, THERE ARE REPORTS THAT ONCE SENSITIZED AN INDIVIDUAL CAN EXPERIENCE THESE SYMPTOMS UPON EXPOSURE TO
DUST, COLD AIR OR OTHER IRRITANTS. THIS INCREASED LUNG SENSITIVITY CAN PERSIST FOR WEEKS AND IN SEVERE CASES FOR
SEVERAL YEARS. CHRONIC OVEREXPOSURE TO ISOCYANATE HAS ALSO BEEN REPORTED TO CAUSE LUNG DAMAGE (INCLUDING
DECREASE IN LUNG FUNCTION) WHICH MAY BE PERMANENT. SENSITIZATION CAN EITHER BE TEMPORARY OR PERMANENT.
HEALTH HAZARDS: ACUTE: EXPOSURE MAY CAUSE MUCOUS MEMBRANE AND RESPIRATORY TRACT IRRITATION, TIGHTNESS OF
CHEST, HEADACHE, SHORTNESS OF BREATH, AND A DRY COUGH. AT CONCENTRATIONS EXCEEDING CURRENT OCCUPATIONAL LIMITS
AND FOR SENSITIZED INDIVIDUALS AT LEVELS LESS THAN OR GREATER THAN CURRENT OCCUPATIONAL LIMITS. ASTHMA-LIKE
SYMPTOMS MAY OCCUR. THESE SYMPTOMS MAY INCLUDE COUGHING, WHEEZING, AND SHORTNESS OF BREATH. A HYPERSENSITIVE
PNEUMONITIS MAY ALSO OCCUR IF THE PERSON IS SENSITIZED. THIS SYNDROME IS CHARACTERIZED BY FEVER, NONPRODUCTIVE
COUGH, WHEEZING, CHILLS, AND SHORTNESS OF BREATH. DIZZINESS, ANESTHESIA, DROWSINESS, UNCONSCIOUSNESS AND OTHER
CENTRAL NERVOUS SYSTEM EFFECTS MAYALSO RESULT. THE EFFECTS OF ACUTE EXPOSURE MAY BE DELAYED IN ONSET UP TO 12-
24 HOURS. CHRONIC: REPEATED EXPOSURE ABOVE CURRENT OCCUPATIONAL LIMITS MAY CAUSE AN ALLERGIC SENSITIZATION OF
THE RESPIRATORY TRACT. THIS IS CHARACTERIZED BY AN ASTHMA-LIKE RESPONSE UPON RE-EXPOSURE TO THE CHEMICAL. THE
SYMPTOMS MAY INCLUDE COUGHING, WHEEZING, SHORTNESS OF BREATH AND CHEST TIGHTNESS. CENTRAL NERVOUS SYSTEM
(CNS) IMPAIRMENT POSSIBLY LEADING TO UNCONSCIOUSNESS.
CARCINOGENICITY: NTP: YES IARC MONOGRAPHS: YES OSHA REGULATED: NO
NTP: THE NATIONAL TOXICOLOGY PROGRAM REPORTED THAT TDI CAUSED AN INCREASE IN THE NUMBER OF TUMORS IN EXPOSED
RATS OVER THOSE COUNTED IN NON-EXPOSED RATS. THE TDI WAS ADMINISTERED IN CORN OILAND INTRODUCED INTO THE STOM-
ACH THROUGH A TUBE. BASED ON THIS STUDY, THE NTP HAS LISTED TDI AS A SUBSTANCE THAT MAY REASONABLY BE ANTICIPATED
TO BE A CARCINOGEN.
IARC: IARC HAS ANNOUNCED THAT IT WILL LIST TDI AS A SUBSTANCE FOR WHICH THERE IS SUFFICIENT EVIDENCE FOR ITS CARCINO-
GENICITY IN EXPERIMENTAL ANIMALS BUT INADEQUATE EVIDENCE FOR THE CARCINOGENICITY OF TDI TO HUMANS (IARC MONO-
GRAPH 39).
IARC CLASSIFIES CARBON BLACK AS A CATEGORY 2B CARCINOGEN (KNOWN ANIMAL CARCINOGEN, POSSIBLE HUMAN CARCINOGEN)
BASED ON INHALATION STUDIES. BECAUSE THIS PRODUCT IS A FREE-FLOWING LIQUID OR PASTE, DUST INHALATION IS NOT AN
EXPECTED ROUTE OF EXPOSURE. SANDING CURED PRODUCT CAN RESULT IN EXPOSURE TO CARBON BLACK DUSTING.
MEDICAL CONDITIONS GENERALLY AGGRAVATED BY EXPOSURE: CARDIOVASCULAR DISEASE, ASTHMA OR ASTHMATIC
BRONCHITIS EMPHYSEMA, ALLERGIC DISEASE, CHRONIC RESPIRATORY DISEASE, SINUSITIS, HEADACHE AND DIZZINESS.
EMERGENCY AND FIRST AID PROCEDURES: EYE CONTACT: IMMEDIATELY FLUSH EYES WITH PLENTY OF WATER, PREFERABLY
LUKEWARM. AFTER INITIAL FLUSHING, REMOVE ANY CONTACT LENSES AND CONTINUE FLUSHING FOR AT LEAST 15 MINUTES. HAVE
EYES EXAMINED AND TREATED BY MEDICAL PERSONNEL. INHALATION: REMOVE VICTIM TO FRESH AIR. IF NOT BREATHING, GIVE
ARTIFICIAL RESPIRATION, PREFERABLY MOUTH-TO-MOUTH. IF BREATHING IS LABORED, GIVE OXYGEN. CONSULT MEDICAL
PERSONNEL. SKIN CONTACT: WASH MATERIAL OFF OF THE SKIN WITH PLENTY OF SOAP AND WATER. IF REDNESS, ITCHING. OR A
BURNING SENSATION DEVELOPS. GET MEDICAL ATTENTION. WASH CONTAMINATED CLOTHING AND DECONTAMINATE FOOTWEAR
BEFORE REUSE. INGESTION: DO NOT INDUCE VOMITING. GIVE 1 OR 2 GLASSES OF WATER TO DRINK AND REFER PERSON TO
MEDICAL PERSONNEL. (DO NOT GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON)
Page 2 of 4 DURA-FLEX-SF
SECTION VI - PRECAUTIONS FOR SAFE HANDLING AND USE
STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED: WEAR SKIN, EYE, AND RESPIRATORY PROTECTION
DURING CLEANUP. SOAK UP MATERIAL WITH ABSORBENT AND SHOVEL INTO A CHEMICAL WASTE CONTAINER. COVER CONTAINER,
BUT DO NOT SEAL, AND REMOVE FROM WORK AREA. PREPARE A DECONTAMINATION SOLUTION OF 2.0% LIQUID DETERGENT AND 3-
8% CONCENTRATED AMMONIUM HYDROXIDE IN WATER (5-10% SODIUM CARBONATE MAY BE SUBSTITUTED FOR THE AMMONIUM
HYDROXIDE). FOLLOW THE PRECAUTIONS ON THE SUPPLIERS MATERIAL SAFETY DATA SHEETS. ALL OPERATIONS SHOULD BE
PERFORMED BY TRAINED PERSONNEL FAMILIAR WITH THE HAZARDS OF THE CHEMICALS USED. TREAT THE SPILL AREA WITH THE
DECONTAMINATION SOLUTION USING ABOUT 10 PARTS OF SOLUTION FOR EACH PART OF THE SPILL AND ALLOW IT TO REACT FOR AT
LEAST 15 MINUTES. CARBON DIOXIDE WILL BE EVOLVED. LEAVING INSOLUBLE POLYUREAS, RESIDUES FROM SPILL CLEANUP, EVEN
WHEN TREATED AS DESCRIBED, MAY CONTINUE TO BE REGULATED UNDER PROVISIONS OF RCRAAND REQUIRE STORAGE AND
DISPOSALAS HAZARDOUS WASTE. FOR MAJOR SPILLS, CALL CHEMTREC (CHEMICAL TRANSPORTATION EMERGENCY CENTER) AT 800-
424-9300.
WASTE DISPOSAL METHOD: SLOWLY STIR THE ISOCYANATE WASTE INTO THE DECONTAMINATION SOLUTION DESCRIBED ABOVE.
LET STAND FOR 48 HOURS, ALLOWING THE EVOLVED CARBON DIOXIDE TO VENT AWAY. RESIDUES MAY STILL BE SUBJECT TO RCRA
STORAGE AND DISPOSAL REQUIREMENTS. DISPOSE OF IN COMPLIANCE WITH ALL RELEVANT LOCAL, STATE, AND FEDERAL LAWS AND
REGULATIONS REGARDING TREATMENT.
PRECAUTIONS TO BE TAKEN IN HANDLING AND STORING: KEEP IN COOL, DRY, VENTILATED STORAGE AREA, IN CLOSED CON-
TAINERS AND OUT OF DIRECT SUNLIGHT.STORE IN CONTAINERS ABOVE GROUND AND SURROUNDED BY DIKES TO CONTAIN SPILLS OR
LEAKS. SUFFICIENT HEAT OR PRESSURE MAY IGNITE OR DETONATE EVEN LIQUID PRODUCT IN THE ABSENCE OF SPARKS OR OPEN
FLAME. KEEP CONTAINERS CLOSED WHEN NOT IN USE.
OTHER PRECAUTIONS: PREVENT SKIN AND EYE CONTACT, OBSERVE TLV LIMITATIONS. AVOID BREATHING VAPORS. WORKERS
SHOULD SHOWER AND CHANGE TO FRESH CLOTHING AFTER EACH SHIFT. A SENSITIZED INDIVIDUAL SHOULD NOT BE EXPOSED TO
THE PRODUCT WHICH CAUSED THE SENSITIZATION. AIR CIRCULATION AND EXHAUSTION OF ISOCYANATE VAPORS MUST BE MAINTAINED
UNTIL THE COATINGS HAVE FULLY CURED TO INSURE THAT NO POTENTIAL HEALTH HAZARD REMAINS. WARNING PROPERTIES
(IRRITATION OF THE EYES, NOSE AND THROAT OR ODOR) ARE NOT ADEQUATE TO PREVENT CHRONIC OVEREXPOSURE FROM
INHALATION. THIS PRODUCT CAN PRODUCE ASTHMATIC SENSITIZATION UPON EITHER SINGLE INHALATION EXPOSURE TO A RELATIVELY
HIGH CONCENTRATION OR UPON REPEATED INHALATION EXPOSURE TO LOWER CONCENTRATIONS. EXPOSURE TO VAPORS OF HEATED
ISOCYANATES CAN BE EXTREMELY DANGEROUS. EMPLOYEE EDUCATION AND TRAINING IN SAFE HANDLING OF THIS MATERIAL IS
REQUIRED UNDER OSHA HAZARD COMMUNICATION STANDARD. INDIVIDUALS WITH EXISTING RESPIRATORY DISEASE SUCH AS
CHRONIC BRONCHITIS, EMPHYSEMA, OR ASTHMA SHOULD NOT BE EXPOSED TO ISOCYANATES. THESE INDIVIDUALS SHOULD BE IDEN-
TIFIED THROUGH BASELINE AND ANNUAL EVALUATION AND REMOVED FROM FURTHER EXPOSURE MEDICAL EXAMINATION SHOULD
INCLUDE MEDICAL HISTORY, VITAL CAPACITY, AND FORCED EXPIRATION VOLUME AT ONE SECOND.
VENTILATION: USE LOCAL EXHAUST VENTILATION TO KEEP AIRBORNE CONCENTRATIONS BELOW THE TLV. FOLLOW GUIDELINES IN
THE ACGIH PUBLICATION "INDUSTRIAL VENTILATION".
SECTION V I - CONTROL MEASURES
RESPIRATORY PROTECTION: IF AIRBORNE CONCENTRATIONS EXCEED OR ARE EXPECTED TO EXCEED THE TLV. USE MSHA/NIOSH
APPROVED POSITIVE PRESSURE SUPPLIED AIR RESPIRATOR WITH A FULL FACE PIECE OR AN AIR SUPPLIED HOOD. FOR EMERGENCIES.
USE A POSITIVE PRESSURE SELF-CONTAINED BREATHING APPARATUS. AIR PURIFYING (CARTRIDGE TYPE) RESPIRATORS ARE
NOTAPPROVED FOR PROTECTION AGAINST ISOCYANATES.
PROTECTIVE CLOTHING: GLOVES DETERMINED TO BE IMPERVIOUS UNDER THE CONDITIONS OF USE SHOULD BE WORN ALWAYS
WHEN WORKING WITH THIS PRODUCT. DEPENDING ON CONDITIONS OF USE, ADDITIONAL PROTECTION MAY BE REQUIRED SUCH AS
APRON, ARM COVERS, OR FULL BODY SUIT. WASH CONTAMINATED CLOTHING BEFORE REWEARING. PROTECTIVE CLOTHING SHOULD
BE SELECTED AND USED IN ACCORDANCE WITH "GUIDELINES FOR THE SELECTION OF CHEMICAL PROTECTIVE CLOTHING" PUBLISHED
BYACGIH.
EYE PROTECTION: CHEMICAL TIGHT GOGGLES OR FULL FACE SHIELD.
OTHER PROTECTIVE EQUIPMENT AND MEASURES: UNHINDERED ACCESS TO SAFETY SHOWER AND EYE WASH STATIONS. AS A
GENERAL HYGIENIC PRACTICE, WASH HANDS AND FACE AFTER USE. SHOWERS AND CLEANING OF CLOTHES ARE RECOMMENDED. FOL-
LOW ALL LABEL INSTRUCTIONS. EDUCATE AND TRAIN EMPLOYEES IN SAFE USE OF PRODUCT.
SECTION IX-REGULATORY INFORMATION
DOT PROPER SHIPPING NAME: NOT REGULATED.
STATE REGULATIONS: CALIFORNIA - AS PER REQUIREMENTS OF THE SAFE DRINKING WATER & TOXIC ENFORCEMENT ACT OF CA.
U.S.A. 1985 (PROPOSITION 65). THE PUBLIC IS WARNED THAT MATERIALS USED IN THIS PRODUCT MAY CREATE AN EXPOSURE TO
CHEMICALS KNOWN TO THE STATE OF CALIFORNIA TO CAUSE CANCER, BIRTH DEFECTS, OR OTHER REPRODUCTIVE HARM. THIS
WARNING REQUIRED BY SECTION 25249.6 OF THE CALIFORNIA HEALTH AND SAFETY CODE.
Page 3 of 4 DURA-FLEX-SF
TOXIC SUBST ANCE CONTROL ACT: ALL CHEMICALS COMPRISING THIS PRODUCT ARE LISTED ON THE
TSCA INVENTORY.
DISCLAIMER: THE INFORMATION CONTAINED HEREIN IS, TO THE BEST OF OUR KNOWLEDGE AND BELIEF,
ACCURATE AND CURRENT AS OF THE DATE OF THIS MSDS. HOWEVER, SINCE THE CONDITIONS OF HANDLING
AND USE ARE BEYOND OUR CONTROL, WE MAKE NO GUARANTEE OF RESULTS, AND ASSUME NO LIABILITY FOR
DAMAGES INCURRED BY USE OF THIS MATERIAL. ALL CHEMICALS MAY PRESENT UNKNOWN HEALTH HAZARDS
AND SHOULD BE USED WITH CAUTION. ALTHOUGH CERTAIN HAZARDS ARE DESCRIBED HEREIN, WE CANNOT
GUARANTEE THAT THESE ARE THE ONLY HAZARDS WHICH EXIST. FINAL DETERMINATION OF SUITABILITY OF
THE CHEMICAL IS THE SOLE RESPONSIBILITY OF THE USER. NO REPRESENTATIONS OR WARRANTIES, EITHER
EXPRESSED OR IMPLIED, OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR ANY OTHER
NATURE ARE MADE HEREUNDER WITH RESPECT TO THE INFORMATION CONTAINED HEREIN OR THE CHEMICAL
TO WHICH THE INFORMATION REFERS. IT IS THE RESPONSIBILITY OF THE USER TO COMPLY WITH
ALLAPPLICABLE FEDERAL, STATE AND LOCAL LAWS AND REGULATIONS.
Page 4 of 4 DURA-FLEX-SF
|